Gender DysphoriaNCT05884307
Trans Care: An Online Intervention to Reduce Symptoms of Gender Dysphoria
A study testing Trans Care Web App in people with Gender Dysphoria, run by University of Wisconsin, Madison at 1 site in United States.
Trial summary
The current project aims to improve the well-being of trans and nonbinary (TNB) individuals through an online intervention (Trans Care) targeting the reduction of symptoms of gender dysphoria. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Gender Dysphoria
- What is being tested?
- Trans Care Web App
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 138 participants
- Where
- 1 siteUnited States
- Study dates
- 23 May 2024to 28 Aug 2024
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Identify as transgender, transsexual, nonbinary, and/or have a transgender history.
- Experience gender dysphoria.
- Time available to commit to completing a 4-5-hour online intervention and 1-2 hours to complete follow up surveys
Who cannot join
- under 18 years old
- individual does not identify as transgender, transsexual, nonbinary, and/or have a transgender history
- does not experience gender dysphoria
- is unable to commit to the time requirements of the study
- does not have access to an internet compatible device
Trial locations and contacts
1 site in 1 country.
About this study
The current project aims to improve the well-being of trans and nonbinary (TNB) individuals through an online intervention (Trans Care) targeting the reduction of symptoms of gender dysphoria. The Trans Care intervention will involve the creation of an online intervention comprised of eight modules intended to reduce symptoms of gender dysphoria, increase active coping, and improve the well-being of TNB individuals. Aim 1 is a feasibility and acceptability study of the proposed intervention and will enroll 100 TNB participants to provide feedback to inform a follow-up randomized controlled trial.
Read the detailed description
The overall purpose of this project is to create a free intervention that can be disseminated widely throughout TNB communities to improve well-being in an easy, accessible way. Development and execution of the Trans Care intervention involves two primary aims:
- Aim 1) Feasibility and acceptability analysis (FAA) [represented by this study record]
- Aim 2) A pilot randomized controlled trial (RCT) of Trans Care's efficacy [to be registered to a separate study record]
Aim 1 involves qualitative and quantitative feedback regarding the content of the Trans Care intervention modules, impact on TNB participants well-being, and feasibility and acceptability of Trans Care intervention. Results from the FAA study will then be analyzed and presented to our community partners who will help us develop modifications to Trans Care to increase its efficacy and ease of use.
Aim 1 Hypotheses:
- The investigators expect that qualitative responses from participants in the FAA study overall will reflect that the Trans Care intervention was feasible and helpful. Any proposed changes from participants' qualitative responses will be incorporated into the final Trans Care intervention presented in the RCT.
- The investigators expect that participants in the FAA study will endorse high scores three scale assessment of feasibility and acceptability.
Aim 1 Endpoints:
The primary endpoint of the study is to determine if the Trans Care intervention is feasible and helpful to TNB individuals for improving their coping strategies. This will be determined through qualitative prompts and a quantitative measure of feasibility and acceptability.
- Conditions
- Gender Dysphoria
- Being tested
- Trans Care Web App
- Keywords
- coping, trans and nonbinary, online intervention, gender minority stress
- Medical subject headings
- Gender Dysphoria
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Trans Care Web AppOther
an educational and interactive website designed to improve coping strategies of TNB individuals
| Study group | Role | What they receive |
|---|---|---|
| Trans and Nonbinary Adults | Experimental | Not described Receives: Other: Trans Care Web App |
What is being measured
The primary outcome is the main question the study is designed to answer.
Acceptability of Intervention Measure (AIM) Score
The AIM is a 4-item measure of intervention acceptability, each item is rated on a 1-5 scale, with 1 = not at all acceptable and 5 = very acceptable. Total mean scores range from 1 - 5, higher scores indicate higher acceptability.
Measured: post intervention (intervention can take up to 5 hours to complete, participant has up to 1 month to complete it)
Intervention Appropriateness Measure (IAM) Score
IAM is a 4-item measure of intervention appropriateness, each item is rated on a 1-5 scale, with 1 = not at all acceptable and 5 = very acceptable. A total mean score ranges from 1 - 5, higher scores indicate higher appropriateness.
Measured: post intervention (intervention can take up to 5 hours to complete, participant has up to 1 month to complete it)
Feasibility of Intervention Measure (FIM) Score
FIM is a 4-item measure of intervention feasibility, each item is rated on a 1-5 scale, with 1 = not at all acceptable and 5 = very acceptable, with a total mean score ranging from 1 to 5, higher scores indicate higher feasibility.
Measured: post intervention (intervention can take up to 5 hours to complete, participant has up to 1 month to complete it)
Summary of Qualitative Prompts
Participants will be given four prompts to qualitatively assess their experience with the intervention. What you liked most? What would you change? What was most helpful? and What was least helpful?
Thematic analysis will be conducted to analyze participants' responses to determine predominant changes suggested by participants
Measured: post intervention (intervention can take up to 5 hours to complete, participant has up to 1 month to complete it)
Trans Care Intervention Specific Feasibility and Acceptability Score
This measure is score from 0 to 4 in each of 5 domains: overall assessment, helpfulness, instructions, videos, and activities. Higher scores indicate higher feasibility and acceptability.
Measured: post intervention (intervention can take up to 5 hours to complete, participant has up to 1 month to complete it)
Digital Working Alliance Inventory (D-WAI) Score
The D-WAI is scored from 7-point Likert-type scale from 1 (strongly disagree) to 7 (strongly agree), for a total range of scores from 7-42 where higher scores indicate higher perceived app effectiveness.
Measured: post intervention (intervention can take up to 5 hours to complete, participant has up to 1 month to complete it)
Secondary outcomes (8)
Depression, Anxiety, and Stress Scale (DASS-21) Score
DASS-21 is scored from 0-3 in each of 3 domains: depression, anxiety, and stress. Higher scores mean increased depression, anxiety, and stress.
Measured: baseline and post intervention (intervention can take up to 5 hours to complete, participant has up to 1 month to complete it)
Gender Congruence and Life Satisfaction Scale (GCLS) Score
GCLS asks participants to think about how they have felt over the last 6 months. Responses are scored on a 5-point Likert scale (always = 1; never = 5). A higher scores mean greater gender congruence, greater gender-related well-being, and greater life satisfaction.
Measured: baseline and post intervention (intervention can take up to 5 hours to complete, participant has up to 1 month to complete it)
Modified Gender Minority Stress and Resilience Measure (M-GMSRM) Score
M-GMSRM is scored from 0-100 where higher scores indicate higher stress.
Measured: baseline and post intervention (intervention can take up to 5 hours to complete, participant has up to 1 month to complete it)
Trans and Nonbinary Coping Measure (TNCM) Score
TNCM is scored from 0-5 where higher scores indicate greater frequency of utilization of coping strategy in each of 6 domains: Social Support / Connection, Social Activism, Hope, Strategic Gender Expression, Behavioral Avoidance, Identity Non-Disclosure.
Measured: baseline and post intervention (intervention can take up to 5 hours to complete, participant has up to 1 month to complete it)
Brief Cope Score
The Brief Cope survey is scored from 1-4 in each of 3 domains: problem-focused coping, emotion-focused coping, and avoidant-coping. Higher scores indicate increased coping mechanisms.
Measured: baseline and post intervention (intervention can take up to 5 hours to complete, participant has up to 1 month to complete it)
Alcohol Use Disorder Identification Test
This is scored from 0-40 where higher scores are indicative of increased dependence on alcohol.
Measured: baseline and post intervention (intervention can take up to 5 hours to complete, participant has up to 1 month to complete it)
Number of Days in the Past Week You Consumed Alcohol
7 = 7 days, 6 = 6 days, 5 = 5 days, 4 = 4 days, 3 = 3 days, 2 = 2 days, 1 = 1 day, 0 = no days
Measured: baseline and post intervention (intervention can take up to 5 hours to complete, participant has up to 1 month to complete it)
Quantity of Alcohol Use
How many alcoholic drinks, on average, have you had per day during the past week? An alcoholic drink is defined as 1 beer, 1 glass of wine, 1 shot of alcohol, or 1 mixed drink.
Response options:
5 = 12+ drinks, 4 = 8-11 drinks, 3 = 5-7 drinks, 2 = 3-4 drinks, 1 = 1-2 drinks, 0 = none
Measured: baseline and post intervention (intervention can take up to 5 hours to complete, participant has up to 1 month to complete it)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted1 Jun 2023
- Study start23 May 2024
- Primary completion28 Aug 2024
- Study completion28 Aug 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Gender DysphoriaStudies of the same condition, open and under way.
- More trials run by University of Wisconsin, MadisonThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 138 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Wisconsin, Madison
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Stephanie Budge, PhD, LP, Principal investigator, University of Wisconsin, Madison
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05884307
- Sponsor's protocol ID
- 2023-0644: FAA
- Other IDs
- UW Baldwin Endowment, Protocol Version 11/7/2023, A171600
- Status last verified
- Sep 2024
- First submitted
- 22 May 2023
- Last updated
- 19 Sep 2024
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 19 Sep 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Trans Care: An Online Intervention to Reduce Symptoms of Gender Dysphoria
- ClinicalTrials.gov ID
- NCT05884307
- Acronym / sponsor ID
- 2023-0644: FAA
- Conditions
- Gender Dysphoria
- Keywords
- coping, trans and nonbinary, online intervention, gender minority stress
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 138 participants (actual)
- Lead sponsor
- University of Wisconsin, MadisonUniversity, hospital or other
- Study start
- 23 May 2024 (actual)
- Primary completion
- 28 Aug 2024 (actual)
- Study completion
- 28 Aug 2024 (actual)
- First posted
- 1 Jun 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The current project aims to improve the well-being of trans and nonbinary (TNB) individuals through an online intervention (Trans Care) targeting the reduction of symptoms of gender dysphoria. The Trans Care intervention will involve the creation of an online intervention comprised of eight modules intended to reduce symptoms of gender dysphoria, increase active coping, and improve the well-being of TNB individuals. Aim 1 is a feasibility and acceptability study of the proposed intervention and will enroll 100 TNB participants to provide feedback to inform a follow-up randomized controlled trial.
Detailed description
The overall purpose of this project is to create a free intervention that can be disseminated widely throughout TNB communities to improve well-being in an easy, accessible way. Development and execution of the Trans Care intervention involves two primary aims:
- Aim 1) Feasibility and acceptability analysis (FAA) [represented by this study record]
- Aim 2) A pilot randomized controlled trial (RCT) of Trans Care's efficacy [to be registered to a separate study record]
Aim 1 involves qualitative and quantitative feedback regarding the content of the Trans Care intervention modules, impact on TNB participants well-being, and feasibility and acceptability of Trans Care intervention. Results from the FAA study will then be analyzed and presented to our community partners who will help us develop modifications to Trans Care to increase its efficacy and ease of use.
Aim 1 Hypotheses:
- The investigators expect that qualitative responses from participants in the FAA study overall will reflect that the Trans Care intervention was feasible and helpful. Any proposed changes from participants' qualitative responses will be incorporated into the final Trans Care intervention presented in the RCT.
- The investigators expect that participants in the FAA study will endorse high scores three scale assessment of feasibility and acceptability.
Aim 1 Endpoints:
The primary endpoint of the study is to determine if the Trans Care intervention is feasible and helpful to TNB individuals for improving their coping strategies. This will be determined through qualitative prompts and a quantitative measure of feasibility and acceptability.
Study design
- Primary purpose
- Supportive care
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Trans and Nonbinary Adults | Experimental | Other: Trans Care Web App |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- Identify as transgender, transsexual, nonbinary, and/or have a transgender history.
- Experience gender dysphoria.
- Time available to commit to completing a 4-5-hour online intervention and 1-2 hours to complete follow up surveys
Key exclusion criteria (5 listed)
- under 18 years old
- individual does not identify as transgender, transsexual, nonbinary, and/or have a transgender history
- does not experience gender dysphoria
- is unable to commit to the time requirements of the study
- does not have access to an internet compatible device
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Trans Care Web Appan educational and interactive website designed to improve coping strategies of TNB individuals | Other | Trans and Nonbinary Adults |
Primary outcome
Acceptability of Intervention Measure (AIM) Score
Time frame: post intervention (intervention can take up to 5 hours to complete, participant has up to 1 month to complete it)
The AIM is a 4-item measure of intervention acceptability, each item is rated on a 1-5 scale, with 1 = not at all acceptable and 5 = very acceptable. Total mean scores range from 1 - 5, higher scores indicate higher acceptability.
Intervention Appropriateness Measure (IAM) Score
Time frame: post intervention (intervention can take up to 5 hours to complete, participant has up to 1 month to complete it)
IAM is a 4-item measure of intervention appropriateness, each item is rated on a 1-5 scale, with 1 = not at all acceptable and 5 = very acceptable. A total mean score ranges from 1 - 5, higher scores indicate higher appropriateness.
Feasibility of Intervention Measure (FIM) Score
Time frame: post intervention (intervention can take up to 5 hours to complete, participant has up to 1 month to complete it)
FIM is a 4-item measure of intervention feasibility, each item is rated on a 1-5 scale, with 1 = not at all acceptable and 5 = very acceptable, with a total mean score ranging from 1 to 5, higher scores indicate higher feasibility.
Summary of Qualitative Prompts
Time frame: post intervention (intervention can take up to 5 hours to complete, participant has up to 1 month to complete it)
Participants will be given four prompts to qualitatively assess their experience with the intervention. What you liked most? What would you change? What was most helpful? and What was least helpful? Thematic analysis will be conducted to analyze participants' responses to determine predominant changes suggested by participants
Trans Care Intervention Specific Feasibility and Acceptability Score
Time frame: post intervention (intervention can take up to 5 hours to complete, participant has up to 1 month to complete it)
This measure is score from 0 to 4 in each of 5 domains: overall assessment, helpfulness, instructions, videos, and activities. Higher scores indicate higher feasibility and acceptability.
Digital Working Alliance Inventory (D-WAI) Score
Time frame: post intervention (intervention can take up to 5 hours to complete, participant has up to 1 month to complete it)
The D-WAI is scored from 7-point Likert-type scale from 1 (strongly disagree) to 7 (strongly agree), for a total range of scores from 7-42 where higher scores indicate higher perceived app effectiveness.
8 secondary outcomes
Depression, Anxiety, and Stress Scale (DASS-21) Score
Time frame: baseline and post intervention (intervention can take up to 5 hours to complete, participant has up to 1 month to complete it)
Gender Congruence and Life Satisfaction Scale (GCLS) Score
Time frame: baseline and post intervention (intervention can take up to 5 hours to complete, participant has up to 1 month to complete it)
Modified Gender Minority Stress and Resilience Measure (M-GMSRM) Score
Time frame: baseline and post intervention (intervention can take up to 5 hours to complete, participant has up to 1 month to complete it)
Trans and Nonbinary Coping Measure (TNCM) Score
Time frame: baseline and post intervention (intervention can take up to 5 hours to complete, participant has up to 1 month to complete it)
Brief Cope Score
Time frame: baseline and post intervention (intervention can take up to 5 hours to complete, participant has up to 1 month to complete it)
Alcohol Use Disorder Identification Test
Time frame: baseline and post intervention (intervention can take up to 5 hours to complete, participant has up to 1 month to complete it)
Number of Days in the Past Week You Consumed Alcohol
Time frame: baseline and post intervention (intervention can take up to 5 hours to complete, participant has up to 1 month to complete it)
Quantity of Alcohol Use
Time frame: baseline and post intervention (intervention can take up to 5 hours to complete, participant has up to 1 month to complete it)
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 19 Sep 2024.
- Study Hypothesis and Design Plan Pre-registered on OSFLink provided by the sponsor.
- Individual participant dataSharing planned: No
Related trials for Gender Dysphoria
Not yet recruiting
QAIAx - SGI/SI Smart Health Cities: Microcity Enclave Program (Quantum SI/AGI Agency a/k/a AI City Hall Project - UPSTO App Nos. 64/074,526, 64/063,557, 64/105,164, 63/903,181, 63/729,428, 64/125,360; USPTO EO 9424 Assignment ID: 2101042 / ARN: REEL/FRAME: 76481/0026 - OUSD-R&E, Department of War)
Asperger's Disorder, Asperger Disorder
RecruitingObservational study
Comparative Study of Gender Identity Disorder Versus Control
Gender Dysphoria, Adult
RecruitingObservational study
China Gender-affirming Hormone Therapy Study
Transgender, Gender Incongruence
RecruitingObservational study
GLOW: Gender-Affirming Care and Mental Health: A Longitudinal Study On Quality of Life, Work Life, and Healthcare Outcomes
Gender Dysphoria, Adult
RecruitingObservational study
Puberty, Testosterone, and Brain Development
Gender Identity, Gender Dysphoria in Adolescents and Adults
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Stephanie Budge, PhD, LP principal investigator
University of Wisconsin, Madison
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Trans Care Web App in people with Gender Dysphoria, run by University of Wisconsin, Madison at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 19 Sep 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Acceptability of Intervention Measure (AIM) Score (time frame: post intervention (intervention can take up to 5 hours to complete, participant has up to 1 month to complete it)). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Sep 2024.